Metabolon awarded patent for metabolomics software

NewsGuard 100/100 Score

Metabolon, Inc. has  announced that it has been awarded a patent for its metabolomics software, Ion Tracker™, which provides a mechanism for creating new chemical library entries.

The software is designed to greatly accelerate and automate the organization of ion features for mass spectrometry into chemically related sets and expedites the creation of a metabolite library. It is a key component of the company’s global biochemical profiling technology.

Corey DeHaven, senior director of information systems with Metabolon, explained, “This tool gives us a unique advantage because we are able to dig very deeply into datasets and find those underlying chemicals that are not already a part of our library, then add them to the library with very little time or effort. It is in this way that Metabolon has been able to build the world’s largest metabolomic reference library and we continue to add to this database daily.”

The awarded patent (US Patent 7'561'975), titled “System, Method, and Computer Program Product for Analyzing Spectrometry Data to Identify and Quantify Individual Component in a Sample,” is the latest addition to Metabolon’s extensive IP portfolio consisting of over 100 US and worldwide patents and patent applications, including broad metabolomics methods, data analysis and biomarker patents, as well as focused product patents.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
SCIEX’s Jose Castro-Perez Reveals How They're Setting New Standards in Mass Spectrometry